Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Dutasteride and Tadalafil
NCT02839122Phase 1Completed
- Sponsor
- Yuyu Pharma
- Start
- May 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dutasteride and tadalafil in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Yuyu Pharma. Primary endpoints: Area Under the Curve (AUC) of Dutasteride and Area Under the Curve (AUC) of Tadalafil. Started May 2016; status: completed.
02
Drugs
dutasteridetadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02839122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02839122.